Dr. Drew Taylor is an accomplished entrepreneur and a leader in the field of regenerative medicine, committed to democratizing access to stem cells so that individuals can leverage their bodies’ own healing potential in future cell-based therapies. His interest in regenerative medicine began in the seventh grade, when he observed a knee replacement surgery. After the procedure, the surgeon mentioned that one day people would be able to use their own cells to heal their bodies. This early insight sparked a lifelong fascination with the potential of regenerative medicine.Balancing academics and athletics, Drew earned his PhD in Biomedical Engineering from the University of Toronto while competing as a professional baseball pitcher. Following an injury that ended his sports career, Drew shifted his focus entirely to medicine, working with the BioEngineering of Skeletal Tissues Team at Mount Sinai Hospital before serving as Chief Science Officer at Epic Capital Management.In 2017, Drew co-founded Acorn Biolabs with the goal of making regenerative medicine more accessible to the public. The company focuses on providing non-invasive, accessible cell banking services, allowing individuals to preserve their own cells for future regenerative therapies. By offering a way to proactively manage health and longevity, Acorn is helping people prepare for the future of medicine, enabling them to live healthier, more vibrant lives as they age.Through his work at Acorn, Dr. Taylor is helping to bridge the gap between cutting-edge scientific advancements and everyday healthcare, ensuring that the benefits of regenerative medicine are available to a wider audience.